William von Oehsen

William von Oehsen, a principal in the firm, has extensive experience in general health law, legislation and policy, especially in the areas of pharmaceuticalpricing, food and drug law, materials management, managed care and third party reimbursement. Bill has more than 30 years of experience on pharmaceuticalpricing and reimbursement matters, including the 340B drug discount program, the Medicaid drug rebate program, Medicare Part D, Robinson-Patman, andstate Medicaid and pharmacy laws. He helped establish and serves as outside counsel to 340B Health, formerly Safety Net Hospitals for Pharmaceutical Access,an advocacy organization of more than 1,200 public and private nonprofit hospitals participating in the 340B program. He played a key role in helping to enactthe 340B program in 1992, as well as to expand the law in 2010 under the Affordable Care Act. In 1997, he helped organize the 340B Coalition, which nowrepresents a dozen national organizations whose members comprise virtually all of the safety net providers participating in the 340B program. Bill co-foundedand served as co-editor of the Drug Discount Monitor, the first publication to focus specifically on the 340B program and other pharmacy access issues. Inaddition to representing 340B Health and other clients on 340B matters, Bill provides guidance to pharmacies, pharmacy-related vendors and consultants,states, local governments, and other healthcare entities in their efforts to improve access to pharmaceutical care and to ensure compliance with drug pricinglaws. He has experience in counseling clients on matters involving the federal supply schedule and federal ceiling price programs, state pharmaceuticalassistance programs, manufacturer patient assistance programs, the Prescription Drug Marketing Act, Medicare Part B, managed care and related authorities.Bill has testified before the U.S. Congress and numerous state legislatures and provides technical assistance to federal and state policy makers in both thelegislative and executive branches. He has handled litigation matters involving pharmaceutical pricing. He also practices in the area of food and drug law. In thefood and drug area, Bill guides companies through the FDA's premarket clearance process; assists companies with product development strategies; provideslabeling, advertising, manufacturing and import/export advice; and handles other issues that arise during the progression from initial clinical testing throughcommercial distribution. He has assisted clients with respect to the development and distribution of medical devices, biologics, food, food additives, dietary
supplements, animal feeds, and cosmetics. He has also defended clients against FDA enforcement actions. Bill is a member of the District of Columbia Bar. Heearned his law degree at Georgetown University Law Center in 1988 and a master's degree from Harvard University in 1984. He earned his undergraduatedegree from Princeton University in 1981. Bill participates in a number of professional organizations including the Food and Drug Law Institute (where he was anAnnual Scholar) and the American Health Lawyers Association. He was also a founding director of the Family AIDS Housing Foundation, now called BuildingFutures: Family AIDS Housing. Bill is the co-author of a book titled Managed Care Manual: Medicaid, Medicare and State Health Reform.